1-4 of 4
Valerie Grose
Close
Sort by
Journal Articles

Reactive Oxygen Species (ROS) Levels Define Functional Heterogeneity in Human Leukemia Stem Cells and Represent a Critical Parameter for Therapeutic Targeting

Eleni Lagadinou, MD/PhD, Kevin Callahan, PhD, Sarah J Neering, BS, ShanShan Pei, BS, Mohammad Minhajuddin, PhD, Randall M Rossi, MS, Valerie Grose, BS, Cheryl Corbett, Marlene Balys, BS, Paul Brookes, PhD, Craig T. Jordan, PhD
Journal: Blood
Blood (2011) 118 (21): 639.
https://doi.org/10.1182/blood.V118.21.639.639
Published: 2011
Journal Articles

Heterogeneity in Phenotype, Functional Capacity, and Drug Sensitivity for Pediatric Acute Leukemia.

Christina M. Wiedl, DO, Terzah M. Horton, MD, PhD, Randall M Rossi, M.S., Sarah J Neering, M.S., Valerie Grose, B.S., Craig T. Jordan, PhD
Journal: Blood
Blood (2009) 114 (22): 2654.
https://doi.org/10.1182/blood.V114.22.2654.2654
Published: 2009
Journal Articles

Rational Combinations Including a Novel Syk Inhibitor, Fostamatinib Disodium (FosD) in Diffuse Large B Cell Lymphoma.

Randall M Rossi, Valerie Grose, Polly Pine, Richard I Fisher, MD, Craig T. Jordan, PhD, Jonathan W. Friedberg, MD
Journal: Blood
Blood (2009) 114 (22): 283.
https://doi.org/10.1182/blood.V114.22.283.283
Published: 2009
Journal Articles

Inhibition of Human Lymphoma Cell Growth by the PKC-Beta Selective Inhibitor Enzastaurin (LY317615) in Combination with Multiple Therapeutic Agents.

Randall M Rossi, Marlene Balys, Dean Franklin, Valerie Grose, Richard I Fisher, Craig Jordan
Journal: Blood
Blood (2008) 112 (11): 1595.
https://doi.org/10.1182/blood.V112.11.1595.1595
Published: 2008